NCT03479580 Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
| NCT ID | NCT03479580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Grenoble |
| Condition | Hypertrophic |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2018-02-08 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2018-02-08 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.
Eligibility Criteria
Inclusion Criteria: * Ischemic * Dilated * Hypertrophic * Restrictive cardiomyopathy. Exclusion Criteria: * Pregnant women * Breastfeeding women * Patients under legal protection
Contact & Investigator
Gilles BARONE-ROCHETTE, PI
PRINCIPAL INVESTIGATOR
University Hospital, Grenoble
Frequently Asked Questions
Who can join the NCT03479580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Hypertrophic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03479580 currently recruiting?
Yes, NCT03479580 is actively recruiting participants. Contact the research team at ccharlon@chu-grenoble.fr for enrollment information.
Where is the NCT03479580 trial being conducted?
This trial is being conducted at La Tronche, France.
Who is sponsoring the NCT03479580 clinical trial?
NCT03479580 is sponsored by University Hospital, Grenoble. The principal investigator is Gilles BARONE-ROCHETTE, PI at University Hospital, Grenoble. The trial plans to enroll 1,600 participants.